KR920006399B1 - Purification of amino peptidase - Google Patents

Purification of amino peptidase Download PDF

Info

Publication number
KR920006399B1
KR920006399B1 KR1019900013631A KR900013631A KR920006399B1 KR 920006399 B1 KR920006399 B1 KR 920006399B1 KR 1019900013631 A KR1019900013631 A KR 1019900013631A KR 900013631 A KR900013631 A KR 900013631A KR 920006399 B1 KR920006399 B1 KR 920006399B1
Authority
KR
South Korea
Prior art keywords
aminopeptidase
precipitate
chromatography
purifying
protein
Prior art date
Application number
KR1019900013631A
Other languages
Korean (ko)
Other versions
KR920004565A (en
Inventor
서정원
박순재
원특연
Original Assignee
럭키 주식회사
최근선
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 럭키 주식회사, 최근선 filed Critical 럭키 주식회사
Priority to KR1019900013631A priority Critical patent/KR920006399B1/en
Publication of KR920004565A publication Critical patent/KR920004565A/en
Application granted granted Critical
Publication of KR920006399B1 publication Critical patent/KR920006399B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A method for purifying aminopeptidase from the fermented broth of Vibrio proteolyticus comprises: (a) filtering the fermented broth with membrane (pore size is 0.1 μm), concentrating and centrifuging to obtain the precipitate; (b) dissolving the precipitate in the zinc sulfate-contg. buffer soln. and heat-treating at 50-70 deg.C for 7-12 hrs.; (c) purifying the heat-treated soln. by gel filtration, anion exchange chromatography and hydrophobic chromatography to obtain the final product. The obtd. aminopeptidase is useful for the prodn. of foods, medicine etc..

Description

비브리오 프로테오리티커스로부터 아미노펩티다제의 정제방법Method for Purifying Aminopeptidase from Vibrio Proteolyticus

제1도는 본 발명의 정제방법에 따라 겔 여과 크로마토그래피한 결과를 나타낸 것이고,1 shows the results of gel filtration chromatography according to the purification method of the present invention,

제2도는 본 발명의 정제방법에 따라 음이온 교환 크로마토그래피한 결과를 나타낸 것이며,2 shows the results of anion exchange chromatography according to the purification method of the present invention,

제3도는 본 발명의 정제방법에 따라 소수성 크로마토그래피한 결과를 나타낸 것이고,3 shows the results of hydrophobic chromatography according to the purification method of the present invention,

제4도는 상기의 각 정제과정에서 얻어진 분획들을 15% 소듐도데실설페이트 아크릴아미드 겔 전기영동(SDS-PAGE)하여 전개한 결과이다.FIG. 4 shows the results obtained by 15% sodium dodecyl sulfate acrylamide gel electrophoresis (SDS-PAGE).

본 발명은 비브리오 프로테오리티커스(Vibrio Proteolyticus)로부터 아미노펩티다제를 정제하는 방법에 관한 것으로서, 보다 상세하게는 비병원성균인 비브리오 프로테오리티커스의 배양액으로부터 루이신-아미노펩티다제를 고순도의 상태로 정제하는 방법에 관한 것이다.The present invention relates to a method for purifying aminopeptidase from Vibrio proteolyticus, and more particularly, to purifying leucine-aminopeptidase from a culture medium of non-pathogenic bacterium Vibrio proteolyticus. It is related with the method of refine | purifying in a state.

단백질을 가수분해하는 효소는 그 기능에 따라 크게 엔도펩티다제와 엑소펩티다제로 구분된다. 아미노펩티다제는 엑소펩티다제에 속하며 생물체내에서 다양하게 존재하는 효소로서, 기질 단백질의 아미노말단으로부터 순차적으로 아미노산을 유리시키는 성질을 가지고 있다. 자연계에는 많은 종류의 아미노펩티다제가 존재하는데, 이 효소들은 아미노말단에 위치하는 아미노산의 종류에 따라 서로 다른 친화력을 보이며, 일반적으로 아미노말단에서 유리되는 아미노산이 소수성 성질을 가지고 있는가 혹은 전하를 띄고 있는가에 따라 효소를 두가지로 크게 분류할 수 있다.Enzymes that hydrolyze proteins are largely divided into endopeptidase and exopeptidase according to their functions. Aminopeptidase belongs to exopeptidase and is an enzyme present in a variety of organisms, and has the property of sequentially releasing amino acids from the amino terminus of a substrate protein. There are many kinds of aminopeptidase in nature, and these enzymes show different affinity depending on the type of amino acid located in the amino terminal. In general, does the amino acid released from the amino terminal have hydrophobic properties or charge? Depending on the enzyme can be divided into two categories.

비브리오 프로테오리티커스의 배양시 발효배지에서 검출되는 아미노펩티다제(EC. 3,4,11,10)는 Prescott와 Wilkes에 의해서 최초로 분리 정제되었다(Arch.The aminopeptidase (EC. 3, 4, 11, 10) detected in fermentation broth in the culture of Vibrio proteolyticus was first isolated and purified by Prescott and Wilkes (Arch.

Biochem. Biophys., 1966, 117 : 328 ; J. Biol. Chem., 1971, 246 : 1756). 이 효소는 대체로 아미노말단에 존재하는 아미노산의 종류에 따른 특이성은 미약한 편이다. 그러나, 유리되는 아미노산이 소수성 아미노산일 경우 가수분해 반응이 전하를 띄는 아미노산경우보다는 빠르게 진행되기 때문에 루이신-아미노펩티다제로 불리게 되었다(Eur. J. Biochem., 1973, 34 : 459). 특히, 단백질이나 올리고펩티드 및 아미노말단으로부터 두번째 위치에 존재하는 아미노산이 음전하를 띄거나 프롤린이면 이 효소에 의한 반응은 더 이상 진전하기가 어렵게 되는 특징이 있다(Methods Enzymol., 1976, 45B : 530).Biochem. Biophys., 1966, 117: 328; J. Biol. Chem., 1971, 246: 1756). This enzyme is generally weak in its specificity depending on the type of amino acid present at the amino terminus. However, when the free amino acid is a hydrophobic amino acid, the hydrolysis reaction proceeds more rapidly than the charged amino acid, which is called leucine-aminopeptidase (Eur. J. Biochem., 1973, 34: 459). In particular, if the amino acid in the second position from the protein, oligopeptide and amino terminus is negatively charged or proline, the reaction by this enzyme is further difficult to progress further (Methods Enzymol., 1976, 45B: 530). .

유전공학 기법에 의해 제조되어 효모나 박테리아에서 발현되는 단백질 의약품들의 경우 아미노말단에 위치한 메티오닌기의 제거에 이 효소가 적절히 응용될 수 있으므로 이 효소의 대량생산과 그에 따른 정제가 요구되게 되었다.Protein drugs manufactured by genetic engineering techniques and expressed in yeast or bacteria can be appropriately applied for the removal of methionine groups located at the amino terminal, which requires mass production and purification of the enzyme.

Prescott와 Wilkes에 의해서 이용된 비브리오 프로테오리티커스의 정제방법은 발효배지를 암모니움 설페이트 처리한 후 유기용매를 처리하여 순도를 증가시키는 방법으로서 칼럼으로는 세파덱스 G-75만이 이용되었다(J. Biol. Chem., 1971, 246 : 1756 ; Methods Enzymol., 1976, 45B : 530).The purification method of Vibrio proteolyticus used by Prescott and Wilkes is a method of increasing the purity by treating the fermentation medium with ammonium sulfate and then treating the organic solvent. Only Sephadex G-75 was used as a column (J. Biol. Chem., 1971, 246: 1756; Methods Enzymol., 1976, 45B: 530).

그러나, 산업적으로 대량 생산하기 위해서는 유기용매 등의 사용은 정제과정상의 부피의 증가 등으로 인하여 효율적인 방법이 아니며, 단백질의약품과의 반응을 위해서는 비브리오균에서 분비되는 이물질들이 오염되지 않은 고순도의 효소가 필요함에 따라 정제 방법상의 개선이 필요하게 되었다.However, for industrial mass production, the use of organic solvents is not an efficient method due to the increase in volume during purification process, and the reaction with protein drugs requires high purity enzymes without contamination of foreign substances secreted from Vibrio bacteria. As a result, improvements in purification methods have been required.

이에 본 발명자들은 상기 문제점을 해결하고자 예의 연구한 결과, 발효 배지로부터 대량 발효된 아미노펩티다제를 고순도로 정제할 수 있는 방법을 개발하게 되었다.Accordingly, the present inventors have intensively researched to solve the above problems, and have therefore developed a method capable of purifying aminopeptidase mass fermented from a fermentation medium with high purity.

즉, 본 발명은 비브리오 프로테오리티커스의 발효배지로부터 아미노펩티다제를 고순도로 대량 정제시킬수 있는 방법을 제공하는 것이다.That is, the present invention provides a method for mass purification of aminopeptidase with high purity from a fermentation medium of Vibrio proteolyticus.

이하 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

본 발명은 비브리오 프로테오리티커스의 발효배지로부터 아미노펩티다제를 정제하는데 있어서, (가) 배양액을 여과 농축한 후 원심분리하여 침전물을 얻고, (나) 상기 침전물을 완충용액에 용해시킨 다음, (다) 겔여과 크로마토그래피하고, (라) 음이온 교환 크로마토그래피한 후, (마) 소수성 크로마토그래피하는 것을 특징으로 하는 비브리오 프로테오리티커스로부터 아미도펩티다제를 정제하는 방법을 제공하는 것이다.In the present invention, in purifying aminopeptidase from a fermentation broth of Vibrio proteolyticus, (A) the culture medium is filtered and concentrated to obtain a precipitate by centrifugation, (B) the precipitate is dissolved in a buffer solution, (C) It provides a method for purifying amidopeptidase from Vibrio proteolyticus, which is subjected to gel filtration chromatography, (D) anion exchange chromatography, and (E) hydrophobic chromatography.

이와 같은 본 발명을 더욱 상세히 설명하면 다음과 같다.Referring to the present invention in more detail as follows.

본 발명의 정제방법에 따로면, 먼저 비브리오 프로테오리티커스 배양액을 포아크기카 0.1μm인 할로우파이버(hollow fiber)에 통과시켜서 세포를 제거한 세포여과액을 얻고, 이 여과액을 농축시킨 다음, 최종 농도가 65%가 되도록 암모니움 설페이트를 첨가하여 4℃에서 방지한다.According to the purification method of the present invention, first, a Vibrio proteolyticus culture medium is passed through a hollow fiber of 0.1 μm pore size to obtain a cell filtrate from which cells are removed, and the filtrate is concentrated. Ammonium sulfate is added to a concentration of 65% and prevented at 4 ° C.

암모니움 설페이트에 의해 침전된 아미노펩티다제 함유액을 원심분리하여 침전물을 얻고, 이를 pH 8.0인트리스 완충용액에 용해시킨 후 50 내지 70℃에서 수시간 열처리하는데, 이때 완충용액중의 단백질농도가 0.5 내지 3mg/ml가 되게 한다.The aminopeptidase-containing solution precipitated by ammonium sulfate was centrifuged to obtain a precipitate, which was dissolved in pH 8.0 intris buffer solution and heat-treated at 50 to 70 ° C for several hours, at which time the protein concentration in the buffer solution 0.5 to 3 mg / ml.

그런 다음, 이를 겔 여과 크로마토그래피하여 필요한 분획을 취합한 후 음이온 교환 크로마토그래피 및 소수성 크로마토그래피하여 정제된 아미노펩티다제를 얻는다.It is then subjected to gel filtration chromatography to collect the required fractions followed by anion exchange chromatography and hydrophobic chromatography to obtain purified aminopeptidase.

이와 같은 본 발명의 정제 과정에서는 완충용액에 황산아연이 함유된 것을 사용한다.In the purification process of the present invention, zinc sulfate is used as the buffer solution.

이하 본 발명을 다음의 실시예에 의거하여 보다 구체적으로 설명하겠다.Hereinafter, the present invention will be described in more detail based on the following examples.

[실시예 1]Example 1

비브리오 프로테오리티커스(ATCC 15388)의 배양액 30l를 연속원심분리기(cepa)로 원심분리하여 배양액을 회수하고 다시 이를 포아크기가 0.1μm인 할로우파이버(Amicon사 제품, H5MPO1-43)에 통과시켜 용액을 모았다. 이때 0.1μM 크기의 포아에 빠지지 않는 세포여과액의 농도가 높아지면 완충용액 I (10mM Tris-HCl, pH 8.0, 100mM NaCl, 50μM 황산아연, 1mM PMSF)로 희석해 주면서 실시하였다. 30l의 세포배양액울 처리하는데 약 5l의 완충용액 I을 사용하는 정도로 세포액을 닦아주었다.Centrifuge 30 l of Vibrio proteolyticus (ATCC 15388) in a continuous centrifuge (cepa) to recover the culture and pass it through a hollow fiber (Amicon, H5MPO1-43) with a pore size of 0.1 μm. Collected. At this time, when the concentration of the cell filtrate that does not fall into 0.1μM pore was increased while diluting with buffer I (10mM Tris-HCl, pH 8.0, 100mM NaCl, 50μM zinc sulfate, 1mM PMSF). The cell solution was wiped to the extent that 5 L buffer I was used to treat 30 L cell culture fluid.

이 세포여과액올 포아크기가 분자량 10,000달톤만 할로우파이버(Amicon사 제품, H10P10-20)로 농축하여 최종적으로 부피가 2l가 되도록 하였다. 이 용액에 포함된 단백질의 양을 BCA 측정법(Pierce사 제품)으로 측정한 결과, 약 6.5g이었다.The pore size of the cell filtrate was concentrated only to hollow fiber (H10P10-20, manufactured by Amicon, H10P10-20) with a molecular weight of 10,000 Daltons to finally have a volume of 2 l. The amount of protein contained in this solution was measured by BCA measurement (Pierce) and found to be about 6.5 g.

[실시예 2]Example 2

상기 실시예 1에서 얻어진 용액(21)을 4℃상태에서 암모니움 설페이트를 730g(최종농도 65%)첨가하여 용해시키고 16시간동안 방치하였다. 이를 8,000rpm에서 30분간 원심분리하여(Beckman사 제품, J-10로터) 침전물을 모은 후 완충용액 I에 용해시켜 최종 단백질농도가 1∼2mg/ml가 되도록 하였다. 단백질용액을 포아크기가 0.45μm인 여과막으로 여과한 후 65℃에서 7∼8시간 동안 열처리 하였다.The solution 21 obtained in Example 1 was dissolved by adding 730 g (final concentration 65%) of ammonium sulfate at 4 ° C. and left for 16 hours. This was centrifuged at 8,000 rpm for 30 minutes (Beckman, J-10 rotor), and the precipitates were collected and dissolved in Buffer I to give a final protein concentration of 1-2 mg / ml. The protein solution was filtered through a membrane having a pore size of 0.45 μm and then heat-treated at 65 ° C. for 7-8 hours.

이 용액을 아미콘 여과막으로 농축하여 단백질농도가 10∼20mg/ml 정도가 되도록 하고, 열처리시 침전된 불용성 물질들을 제거하기 위하여 포아크기가 0.45μm인 여과막(셀룰로즈-아세테이트, Nalgene사 제품)을 통과시킨 후 냉동 보관하였다.The solution was concentrated with an amicon filter membrane to have a protein concentration of about 10-20 mg / ml, and passed through a filtration membrane (cellulose-acetate, manufactured by Nalgene) having a pore size of 0.45 μm to remove insoluble substances precipitated during heat treatment. After frozen storage.

[실시예 3]Example 3

상기 실시예 2에서 얻어진 열처리한 아미노펩티다제 700mg을 완충용액 I로 평형시킨 세파크릴 S-300(15cm×30cm, Pharmacia사 제품) 칼럼에 통과시켜서 겔 여과 크로마토그래피 하였으며, 용출 속도는 약 500ml/시간으로 하였다. 그 결과를 제1도에 나타내었다.700 mg of the heat-treated aminopeptidase obtained in Example 2 was passed through a Sephacryl S-300 (15 cm × 30 cm, Pharmacia) column equilibrated with buffer solution I, and the gel filtration chromatography was performed. The elution rate was about 500 ml /. It was time. The results are shown in FIG.

아미노펩티다제의 활성은 보이드피크 이후에 이어서 바로 나오는 분획에 있었으며 이 분획을 모았을 때의 단백질 양은 약 140mg이었다.The activity of the aminopeptidase was in the fraction immediately following the void peak and the amount of protein when collected was about 140 mg.

아미노펩티다제의 활성을 측정하기 위하여 루이신-파라니트로아닐리드(Leu-pNA)를 기질로 사용하였으며, 완충용액으로는 100mM Tris-HCl, pH 8.0을 이용하였다. 완충용액 1ml에 기질을 최종농도가 1.5mM이 되게 첨가하고, 여기에 단배질이 함유된 칼럼에서 용출된 단백질 함유액을 소량 첨가하여 37℃에서 1분간 반응시켰다. 200μm의 초산액(30% v/v)을 첨가하여 반응을 중지시키고, 곧이어서 405nm에서 흡광도를 측정하였다.In order to measure the activity of aminopeptidase, leucine-paranitroanilide (Leu-pNA) was used as a substrate, and 100 mM Tris-HCl, pH 8.0 was used as a buffer. The substrate was added to 1 ml of the buffer solution to a final concentration of 1.5 mM, and a small amount of the protein-containing solution eluted from the column containing the protein was added thereto and reacted at 37 ° C. for 1 minute. 200 μm of acetic acid solution (30% v / v) was added to stop the reaction, and then the absorbance was measured at 405 nm.

아미노펩티다제가 함유된 분획은 노란색의 발색 반응을 나타내게 된다.Fractions containing aminopeptidase have a yellow color reaction.

[실시예 4]Example 4

상기 실시예 3에 의해 부분 정제된 아미노펩티다제 함유액을 DEAE-셀룰로즈(Pharmacia사 제품, 2.5cm×10cm) 칼럼에서 음이온 교환 크로마토그래피하였다. 즉, 완충용액 I로 평형시킨 칼럼에 단백질함유액을 주입한 후 소금농도가 각각 10mM에서 700mM이 되도록 선형구배를 걸어 단백질을 용출시켰다.The aminopeptidase-containing liquid partially purified by Example 3 was subjected to anion exchange chromatography on a DEAE-cellulose (Pharmacia, 2.5 cm x 10 cm) column. That is, after the protein-containing solution was injected into the column equilibrated with the buffer solution I, the protein was eluted by applying a linear gradient such that the salt concentration was 10 mM to 700 mM, respectively.

그 결과를 제2도에 나타내었는바, 약 200mM의 소금농도에서 아미노펩티다제 활성을 갖는 단백질이 용출되었다.The results are shown in FIG. 2, and the protein having aminopeptidase activity was eluted at a salt concentration of about 200 mM.

이 단계에 의해 약 75mg의 정제된 단백질이 얻어졌다.This step yielded about 75 mg of purified protein.

DEAE-세파로즈 칼럼을 이용한 음이온 교환 크로마토그래피에서도 제2도와 거의 같은 양상의 결과가 나타났다.Anion exchange chromatography using DEAE-Sepharose column showed the same results as in FIG.

[실시예 5]Example 5

상기의 실시예 4에서 얻어진 단백질 75mg을 페닐-세파로즈(Ph-armacia사 제품)칼럼에서 소수성 크로마토그래피하였다. 즉, 완충용액 I에 2M의 소금을 넣은 용액으로 충분히 평형시킨 후 단백질 함유액을 주입하고, 소금의 농도가 0M까지 감소하는 방향으로 베드볼륨의 8배에 이르는 완충용액으로 선형구배하여 아미노펩티다제를 용출시켰다.75 mg of the protein obtained in Example 4 was subjected to hydrophobic chromatography in a phenyl-sepharose (Ph-armacia) column. That is, equilibrate the solution I with 2M of salt and inject the protein-containing solution, and linearly gradient to 8 times the volume of the buffer in the direction of decreasing the salt concentration to 0M. Eluted.

그 결과를 제3도에 나타내었는 바, 소량의 오염 단백질이 페닐-세파로즈 칼럼에 흡착되지 않고 용출되었으며, 선형구배시에 용출되는 단백질은 거의 순수한 아미노펩티다제이었다.The results are shown in FIG. 3, where a small amount of contaminating protein was eluted without adsorption on the phenyl-sepharose column, and the protein eluted at the linear gradient was almost pure aminopeptidase.

이때 얻어진 단백질의 양은 약 68mg이었다.The amount of protein obtained was about 68 mg.

상기의 각 정제과정에서 얻어진 아미노펩티다제 분획을 15% SDS-PAGE하여 전개하고, 그 결과를 제4도에 나타내었다.The aminopeptidase fraction obtained in each of the above purification steps was developed by 15% SDS-PAGE, and the results are shown in FIG.

제4도에서, 제1열은 표준단백질들로서 위로부터 각각 66.2K,42.7K,31.0K,21.5K 및 14.4K달톤의 분자량을 표시하며, 제2열은 발효배시의 여과액을 전개한 것이고, 제3열은 발효배시의 농축액을 전개한것이며, 제4열은 아미노펩티다제가 함유된 발효배지에 암모니움 설페이트를 처리하여 분획한 결과이고, 제5열은 열처리 후의 결과이며, 제6열, 제7열 및 제8열은 각각 겔 여과 크로마토그래피, 음이온 교환 수지 크로마토그래피 및 소수성 크로마토그래피 결과를 나타낸 것이다.In FIG. 4, the first column shows the molecular weights of 66.2K, 42.7K, 31.0K, 21.5K and 14.4K Daltons from above as standard proteins, and the second column shows the filtrate of the fermentation bath. The third column is the development of the concentrate of the fermentation batch, the fourth column is the result of fractionation of ammonium sulfate in the fermentation medium containing aminopeptidase, the fifth column is the result after heat treatment, the sixth column, Rows 7 and 8 show the results of gel filtration chromatography, anion exchange resin chromatography and hydrophobic chromatography, respectively.

제4도에 나타낸 바와 같이 본 발명에 따라 정제된 단백질은 SDS-PAGE상에서 약 29,500달톤임이 확인되었으며, 쿠마시불루 염색한 결과 약 99%의 순도를 나타내었다.As shown in FIG. 4, the purified protein according to the present invention was found to be about 29,500 Daltons on SDS-PAGE, and the Coomasubiru staining showed a purity of about 99%.

Claims (8)

비브리오 프로테오리티커스의 발효배지로부터 아미노펩티다제를 정제하는데 있어서, (가)배양액을 여과 농축한 후, 원심분리하여 침전물을 얻고, (나) 상기 침전물을 완충용액에 용해시킨 다음, (다) 겔 여과크로마토그래피하고, (라) 음이온 교환 크로마토그래피한 후, (마) 소수성 크로마토그래피하는 것을 특징으로 하는 비브리오 프로테오리티커스로부터 아미노펩티다제의 정제방법.In purifying aminopeptidase from a fermentation broth of Vibrio proteolyticus, (A) the culture solution is filtered and concentrated, centrifuged to obtain a precipitate, (B) the precipitate is dissolved in a buffer solution, and A method for purifying aminopeptidase from Vibrio proteolyticus, comprising gel filtration chromatography, (d) anion exchange chromatography, and (e) hydrophobic chromatography. 제1항에 있어서, 상기 (가)단계의 여과시 포아크기가 0.1μm인 분리막을 사용하는 것을 특징으로 하는 방법.The method according to claim 1, wherein the separation membrane having a pore size of 0.1 μm is used in the filtration step (a). 제1항에 있어서, 상기 (나)단계에서 침전물은 완충용액 중에 단백질농도가 0.5 내지 3mg/ml이 되도록 용해시키는 것을 특징으로 하는 방법.The method of claim 1, wherein in step (b), the precipitate is dissolved in a buffer so that the protein concentration is 0.5 to 3 mg / ml. 제1항에 있어서, 상기 (나)단계에서 침전물을 완충용액에 용시킨 후에 50 내지 70℃에서 7 내지 12시간 동안 열처리하는 것을 특징으로 하는 방법.The method according to claim 1, wherein the precipitate is dissolved in a buffer in step (b) and then heat-treated at 50 to 70 ° C. for 7 to 12 hours. 제1항에 있어서, 상기 (다)단계의 젤 여과 크로마토그래피는 수지로서 세파크릴 S-300을 사용하여서 됨을 특징으로 하는 방법.The method of claim 1, wherein the gel filtration chromatography of step (c) is performed using Sephacryl S-300 as a resin. 제1항에 있어서, 상기 (라)단계의 음이온 교환 크로마토그래피는 수지로서 DEAE-셀룰로즈 또는 DEAE-세파로즈를 사용하여서 됨을 특징으로 하는 방법.The method of claim 1, wherein the anion exchange chromatography of step (d) is performed using DEAE-cellulose or DEAE-sepharose as the resin. 제1항에 있어서, 상기 (마)단계의 소수성 크로마토그래피는 수지로서 페닐-세파로즈를 사용하여서 됨을 특징으로 하는 방법.The method according to claim 1, wherein the hydrophobic chromatography of step (e) is performed using phenyl-sepharose as a resin. 제1항에 있어서, 완충용액으로 황산아연을 함유하는 것을 사용하는 것을 특징으로 하는 방법.The method according to claim 1, wherein the buffer solution contains zinc sulfate.
KR1019900013631A 1990-08-31 1990-08-31 Purification of amino peptidase KR920006399B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019900013631A KR920006399B1 (en) 1990-08-31 1990-08-31 Purification of amino peptidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900013631A KR920006399B1 (en) 1990-08-31 1990-08-31 Purification of amino peptidase

Publications (2)

Publication Number Publication Date
KR920004565A KR920004565A (en) 1992-03-27
KR920006399B1 true KR920006399B1 (en) 1992-08-06

Family

ID=19303004

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900013631A KR920006399B1 (en) 1990-08-31 1990-08-31 Purification of amino peptidase

Country Status (1)

Country Link
KR (1) KR920006399B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449125B1 (en) * 1997-04-03 2004-11-26 동아제약주식회사 Method for purifying aminopeptidase m from kidney of pig in higher purity and yield, thereby removing methionine without treatment of protease inhibitor

Also Published As

Publication number Publication date
KR920004565A (en) 1992-03-27

Similar Documents

Publication Publication Date Title
JPS5837833B2 (en) Method for purifying microbial lipoprotein lipase
SU1423002A3 (en) Method of producing protein reducing content of cholesterol in blood of mammals
Hattori et al. Studies on amylolytic enzymes produced by Endomyces sp. Part II. Purification and general properties of amyloglucosidase
JPS6344883A (en) Novel hyaluronidase sd-678 and production thereof
KR920006399B1 (en) Purification of amino peptidase
Aisaka et al. Purification, crystallization, and characterization of neuraminidase from Micromonospora viridifaciens
US3875007A (en) Lipid metabolism improving and anti-atheromatic agent
JPS6279790A (en) Production of modified hyaluronic acid
JP2726274B2 (en) Novel keratan sulfate degrading enzyme and microorganism and method for producing the same
US5723325A (en) Indolyl-3-alkane alpha-hydroxylase compositions from pseudomonas XA
EP0430637B1 (en) Fibrinolytic protein and production method thereof
JPH03247296A (en) Production of low-molecular weight chondroitin sulfate
Brox et al. Inosine-5′-phosphate dehydrogenase of Aerobacter Aerogenes. Studies of tertiary structure
KR100323837B1 (en) Process for the preparation of low-molecular weight levan by using immobilized levansucrase or microorganism cells treated with an organic solvent
EP0059182B1 (en) A process for isolating aminoacylase enzyme from a mammal kidney extract
WO2016076647A1 (en) Method for preparing collagenase and method for preparing collagen tripeptide using same
JPH0556952B2 (en)
KR970002903B1 (en) Purification process of streptokinase
KR970001813B1 (en) Purification process of aminopeptidase by three-phase separation method
US4990450A (en) Method of producing endo-α-N-acetylgalactosaminidase from microorganisms
Shain et al. Purification and properties of a novel glycosaminoglycan depolymerase from Streptococcus intermedius strain UNS 35
KR900003514B1 (en) Purification of interferon
JPS6031479B2 (en) Method for producing pure chondroitinase C
RU2101292C1 (en) Method of isolation of recombinant human tumor necrosis alpha-factor
KR0126427B1 (en) Preparation method of hyaluronic acid

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030701

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee